Your own cells could stop Cancer's return: major trial tests personalized vaccine
Prevention
Not yet recruiting
This study is testing a personalized vaccine called OncoVax to prevent colon cancer from coming back after surgery. The vaccine is made from a patient's own cancer cells and is designed to train the immune system to attack any remaining cancer. The trial will enroll 550 patients …
Phase: PHASE3 • Sponsor: Vaccinogen Inc • Aim: Prevention
Last updated Mar 27, 2026 12:38 UTC